The K⁺ Channel K_Ca3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis

• Katy Morgan Roach,

  Affiliation Institute for Lung Health, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom

  ⨯
• Stephen Mark Duffy,

  Affiliation Institute for Lung Health, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom

  ⨯
• William Coward,

  Affiliation Division of Respiratory Medicine, Centre for Respiratory Research and Nottingham Respiratory Biomedical Research Unit, University of Nottingham, Nottingham, United Kingdom

  ⨯
• Carol Feghali-Bostwick,

  Affiliation Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Heike Wulff,

  Affiliation Department of Pharmacology, University of California Davis, Davis, California, United States of America

  ⨯
• Peter Bradding

  * E-mail: pbradding@hotmail.com

  Affiliation Institute for Lung Health, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom

  ⨯